Andrea L Murphy1, David M Gardner1, Steve Kisely2, Charmaine Cooke3, Stan P Kutcher4, Jean Hughes5. 1. College of Pharmacy, Dalhousie University, Halifax, Nova Scotia ; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia. 2. School of Population Health, University of Queensland, Herston, Queensland, Australia. 3. Department of Health and Wellness, Halifax, Nova Scotia. 4. Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia ; Sun Life Financial Chair in Adolescent Mental Health, Dalhousie University/IWK Health Centre, Halifax, Nova Scotia. 5. School of Nursing, Dalhousie University, Halifax, Nova Scotia.
Abstract
OBJECTIVE: To explore the lived experience of youth who are prescribed antipsychotics. METHODS: We conducted an interpretive phenomenology study of young people with recent experience of taking antipsychotics. Youth were interviewed and a staged approach was used for data analysis of transcriptions. We collected approximately 13 hours of audio from 18 youth aged 13 to 26 years between January and August of 2010. RESULTS: Ambivalence was significant and antipsychotic adverse effects frequently tempered benefits. Both illness and antipsychotics had significant impacts on physical and mental wellbeing with adverse effects on relationships and functioning in various contexts (e.g., school). Stigma related to both antipsychotics and illness was also prominent. Participants' limited knowledge about their antipsychotics and pressure to conform within their youth culture and context affected decisions on starting, adhering to, and persisting with treatment. CONCLUSIONS: The lived experience of youth taking antipsychotics is complex and the benefits (e.g., symptom improvement) and consequences (e.g., adverse effects) associated with antipsychotics affect all facets of life. More research is needed to better understand youth priorities in treatment decisions and whether youth who demonstrate substantive gaps in their knowledge about antipsychotics are truly given the opportunity to be informed and engage in management decisions including whether to initiate, persist with, and discontinue treatments.
OBJECTIVE: To explore the lived experience of youth who are prescribed antipsychotics. METHODS: We conducted an interpretive phenomenology study of young people with recent experience of taking antipsychotics. Youth were interviewed and a staged approach was used for data analysis of transcriptions. We collected approximately 13 hours of audio from 18 youth aged 13 to 26 years between January and August of 2010. RESULTS: Ambivalence was significant and antipsychotic adverse effects frequently tempered benefits. Both illness and antipsychotics had significant impacts on physical and mental wellbeing with adverse effects on relationships and functioning in various contexts (e.g., school). Stigma related to both antipsychotics and illness was also prominent. Participants' limited knowledge about their antipsychotics and pressure to conform within their youth culture and context affected decisions on starting, adhering to, and persisting with treatment. CONCLUSIONS: The lived experience of youth taking antipsychotics is complex and the benefits (e.g., symptom improvement) and consequences (e.g., adverse effects) associated with antipsychotics affect all facets of life. More research is needed to better understand youth priorities in treatment decisions and whether youth who demonstrate substantive gaps in their knowledge about antipsychotics are truly given the opportunity to be informed and engage in management decisions including whether to initiate, persist with, and discontinue treatments.
Authors: Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Andrea L Murphy; David M Gardner; Charmaine Cooke; Steve Kisely; Jean Hughes; Stan P Kutcher Journal: BMC Psychiatry Date: 2013-07-27 Impact factor: 3.630
Authors: Andrea C Bishop; Todd A Boyle; Bobbi Morrison; James R Barker; Bev Zwicker; Tom Mahaffey; Andrea Murphy Journal: Can Pharm J (Ott) Date: 2015-09
Authors: Andrea L Murphy; Ruth Martin-Misener; Stan P Kutcher; Claire L O'Reilly; Timothy F Chen; David M Gardner Journal: BMC Health Serv Res Date: 2016-10-12 Impact factor: 2.655
Authors: Andrea L Murphy; David M Gardner; Steve Kisely; Charmaine A Cooke; Stanley P Kutcher; Jean Hughes Journal: Clin Child Psychol Psychiatry Date: 2015-11-27 Impact factor: 2.544
Authors: Sara S McMillan; Victoria Stewart; Amanda J Wheeler; Fiona Kelly; Helen Stapleton Journal: BMC Public Health Date: 2020-07-30 Impact factor: 3.295